Literature DB >> 567318

Pharmacological alterations of coronary collateral circulation; implication to the steal-phenomenon.

J Wichmann, R Löser, H P Diemer, W Lochner.   

Abstract

Measurements of resistances were performed on different parts of coronary vessels, including spontaneous collaterals in anesthetized dogs, following ligation and embolization of the descending branch of the left coronary artery. The normal situation was compared with the state of maximal pharmacological dilatation. The pharmacological dilatation decreased the collateral resistance by 24% in spite of the fact that the collaterals supplied an infarcted area in this case; the precollateral resistance, which chiefly consists of large vessels was also diminished. The collateral perfusion pressure is not only dependent on the aortic pressure, but also on the flow rate in the corresponding large coronary vessel and thereby on the ratio of precollateral to postcollateal resistance. A decrease of the collateral perfusion pressure causes an insufficient perfusion of the area supplied by the collaterals only when the pressure fall is not compensated for by an adequate decrease in the collateral resistance and when the ratio of the collateral to the nutritive resistance increases. Thus, both, the extent of the pressure fall across the precollateral resistance and the dilating capacity of the collaterals determine whether is not a pharmacological dilatation of the coronary vascular bed results in an insufficient supply of an infarcted area, i.e. in a so called "Steal-phenomenon". The results show further, that the given physical model of the microcirculation satisfactorily approximates the observed behaviour of the vascular system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567318     DOI: 10.1007/bf00580827

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  21 in total

1.  EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA.

Authors:  W M FAM; M MCGREGOR
Journal:  Circ Res       Date:  1964-10       Impact factor: 17.367

2.  [Studies on the function of intra-arterial coronary anastomosis in heart infarct].

Authors:  W MEESMANN
Journal:  Z Kreislaufforsch       Date:  1959-03

3.  Some determinants of coronary collateral blood flow in the open-chest dog.

Authors:  A A KATTUS; D E GREGG
Journal:  Circ Res       Date:  1959-07       Impact factor: 17.367

4.  [Measurement of collateral blood flow in dog hearts by means of selective embolization of a coronary artery].

Authors:  F W Schulz; W K Raff; U Meyer; W Lochner
Journal:  Pflugers Arch       Date:  1973-07-06       Impact factor: 3.657

5.  [Experimental test of the action of coronary dilators in humans].

Authors:  H H Hilger
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

6.  Regulation of coronary blood flow.

Authors:  M McGregor; W M Fam
Journal:  Bull N Y Acad Med       Date:  1966-11

7.  [Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].

Authors:  W Rudolph; L Meixner; H J Künzig
Journal:  Klin Wochenschr       Date:  1967-04-01

8.  Coronary collateral flow: effect of drugs and perfusion pressure.

Authors:  H P Diemer; J Wichmann; W Lochner
Journal:  Basic Res Cardiol       Date:  1977 Jul-Aug       Impact factor: 17.165

9.  Effects of persantin and nitroglycerin on myocardial blood flow during temporary coronary occlusions in dogs.

Authors:  E Linder; T Seeman
Journal:  Angiologica       Date:  1967

10.  Coronary steal: its role in detrimental effect of isoproterenol after acute coronary occlusion in dogs.

Authors:  M V Cohen; E H Sonnenblick; E S Kirk
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

View more
  9 in total

1.  Changes of collateral perfusion pressure and segmental coronary resistances during reactive hyperemia in anesthetized dogs.

Authors:  M Fuchs; G Ertl; A Falcke
Journal:  Pflugers Arch       Date:  1983-12       Impact factor: 3.657

2.  Effects of heart rate and perfusion pressure on segmental coronary resistances and collateral perfusion.

Authors:  G Heusch; N Yoshimoto
Journal:  Pflugers Arch       Date:  1983-06-01       Impact factor: 3.657

3.  A model for the investigation of regional coronary vascular resistances. Physical features as compared with experimental results.

Authors:  F Simm; G Ertl
Journal:  Basic Res Cardiol       Date:  1980 Sep-Oct       Impact factor: 17.165

4.  The pressure-resistance relationships of regional resistances within the coronary circulation and the steal phenomenon.

Authors:  J Wichmann; W Lochner; R Löser; H P Diemer
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

5.  Influence of the ischemic coronary bed on collateral blood flow.

Authors:  G Ertl; M Fuchs; S Oswald; J Wichmann; W Lochner
Journal:  Basic Res Cardiol       Date:  1982 Sep-Oct       Impact factor: 17.165

6.  Effect of prolonged selective intramesenteric arterial vasodilator therapy on intestinal viability after acute segmental mesenteric vascular occlusion.

Authors:  J E Meilahn; J B Morris; E P Ceppa; G B Bulkley
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

7.  The dependence of coronary collateral blood flow on regional vascular resistances. Pharmacological studies with glyceryl trinitrate, adenosine and verapamil.

Authors:  G Ertl; F Simm; J Wichmann; M Fuchs; W Lochner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

8.  Alpha-adrenergic vasoconstriction in arterial and arteriolar sections of the canine coronary circulation.

Authors:  G Ertl; M Fuchs
Journal:  Basic Res Cardiol       Date:  1980 Sep-Oct       Impact factor: 17.165

9.  Low dose calcium-antagonism compensates for impaired myocardial blood supply resulting from deficient nitric oxide synthesis.

Authors:  J Zanzinger; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.